Last reviewed · How we verify

NCT01999634: MTM-COLON-II

Monitoring by Microdialysis of Postoperative Complications After Proctectomy

Completed Phase 3 Last updated 22 September 2025
What this trial tests

Phase 3 trial testing cma microdialysis catheter placement in Rectal Cancer in 21 participants. Completed in 23 March 2017.

Timeline
5 February 2014
Primary endpoint
23 March 2017
23 March 2017

Quick facts

Lead sponsorCentre Hospitalier Universitaire, Amiens
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment21
Start date5 February 2014
Primary completion23 March 2017
Estimated completion23 March 2017
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire, Amiens

Who can join

18 and older, any sex, with Rectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to monitor by microdialysis the postoperative outcomes in order to identify anastomotic leaks after rectal surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Rectal Cancer

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire, Amiens trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01999634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing